← Leaderboards
Efstathios Karathanasis
Case Western Reserve University
$7,023,368
Attributed
$9,368,187
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,368,187 · 4
By mechanism
R01$6,289,789 · 3
U01$3,078,398 · 1
Top collaborators
- William Schiemann5 shared
- Li Lily Wang4 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Zheng-Rong Lu$13,267,567
- William Schiemann$12,636,493
- Cathleen R Carlin$4,237,703
- Ann-Marie Broome$1,431,477
- Thomas E Dick$7,172,255
Others in their field
Top investigators on “Nanoparticle”
- David Heimbrook · Leidos Biomedical Research, Inc.$67,480,937
- Ralph Weissleder · Massachusetts General Hospital$52,944,531
- Robert J Hamers · University Of Wisconsin-Madison$40,936,500
- Gang Bao · Georgia Institute Of Technology$28,866,343
- Barton F Haynes · Duke University$28,645,614
- Bala Raja · Luminostics, Inc.$28,624,460
Research focus
NanoparticleMalignant NeoplasmsTumorExhibitsSiteNeoplastic CellTreatment EfficacyIn VivoDisseminated Malignant NeoplasmDesignToxic EffectCellsNeoplasm MetastasisBlood VesselsNanosphereMicrometastasisCancer CellRecurrenceDoseLigandsLinkDensityCytotoxic AgentDeposition
Grant awards (20)
Dual action immunostimulatory nanoparticles for treatment of aggressive cancers$540,823
R01 · FY2025 · CA · contact PI
Dual action immunostimulatory nanoparticles for treatment of aggressive cancers$570,868
R01 · FY2024 · CA · contact PI
Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis$561,099
R01 · FY2024 · CA · contact PI
Dual action immunostimulatory nanoparticles for treatment of aggressive cancers$77,121
R01 · FY2024 · CA · contact PI
Dual action immunostimulatory nanoparticles for treatment of aggressive cancers$600,913
R01 · FY2023 · CA · contact PI
Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis$578,041
R01 · FY2023 · CA · contact PI
Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis$578,640
R01 · FY2022 · CA · contact PI
Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis$591,126
R01 · FY2021 · CA · contact PI
Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis$591,007
R01 · FY2020 · CA · contact PI
Treatment of glioblastoma using chain-like nanoparticles$534,432
U01 · FY2019 · CA · contact PI
Treatment of glioblastoma using chain-like nanoparticles$64,240
U01 · FY2019 · CA · contact PI
Treatment of glioblastoma using chain-like nanoparticles$561,808
U01 · FY2018 · CA · contact PI
Treatment of glioblastoma using chain-like nanoparticles$617,516
U01 · FY2017 · CA · contact PI
Detection of micrometastasis using a dual-ligand nanoparticle$321,962
R01 · FY2017 · CA · contact PI
Treatment of glioblastoma using chain-like nanoparticles$724,308
U01 · FY2016 · CA · contact PI
Detection of micrometastasis using a dual-ligand nanoparticle$321,962
R01 · FY2016 · CA · contact PI
Treatment of glioblastoma using chain-like nanoparticles$576,094
U01 · FY2015 · CA · contact PI
Detection of micrometastasis using a dual-ligand nanoparticle$321,962
R01 · FY2015 · CA · contact PI
Detection of micrometastasis using a dual-ligand nanoparticle$312,303
R01 · FY2014 · CA · contact PI
Detection of micrometastasis using a dual-ligand nanoparticle$321,962
R01 · FY2013 · CA · contact PI